Kinnate Biopharma Clinical-Stage Oncology Corporate Presentation 2023

Kinnate Biopharma is a clinical-stage precision oncology company developing targeted therapies for cancer. The company's pipeline includes exarafenib (KIN-2787) for BRAF/NRAS-mutant melanoma and KIN-3248 for FGFR-driven cancers, with a proprietary Discovery Engine designed for rapid drug development.